Results 1 to 10 of about 1,661 (50)

Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background It remains unclear whether beta‐blocker use at hospital admission is associated with better in‐hospital outcomes in patients with acute decompensated heart failure.
Yodo Tamaki, Hidenori Yaku, Takeshi Morimoto, Yasutaka Inuzuka, Neiko Ozasa, Erika Yamamoto, Yusuke Yoshikawa, Makoto Miyake, Hirokazu Kondo, Toshihiro Tamura, Takeshi Kitai, Moritake Iguchi, Kazuya Nagao, Ryusuke Nishikawa, Yuichi Kawase, Takashi Morinaga, Mitsunori Kawato, Mamoru Toyofuku, Yukihito Sato, Koichiro Kuwahara, Yoshihisa Nakagawa, Takao Kato, Takeshi Kimura   +22 more
doaj   +1 more source

The Association of Beta-Blocker Use and Bone Mineral Density Level in Hemodialysis Patients: A Cross-Sectional Study

Medicina, 2023
Background and Objectives: Osteoporosis results in increasing morbidity and mortality in hemodialysis patients. The medication for treatment has been limited.
Suthiya Anumas, Saranya Thitisuriyarax, Pichaya Tantiyavarong, Waroot Pholsawatchai, Pattharawin Pattharanitima   +4 more
doaj   +1 more source

A Clinical-Epidemiological Study on Beta-Blocker Poisonings Based on the Type of Drug Overdose

Journal of Toxicology, 2023
Background. Beta‐blockers carry a high risk of potentially causing fatal poisoning if overdosed. We aimed to assess the clinical and epidemiological characteristics of patients with beta-blocker poisoning. Methods.
Nastaran Eizadi-Mood, Mahtab Adib, Arman Otroshi, Gholamali Dorooshi, Rokhsareh Meamar   +4 more
doaj   +1 more source

Beta-blocker use and up-titration after acute ST-segment elevation myocardial infarction: a cohort study

Swiss Medical Weekly, 2020
BACKGROUND The European Society of Cardiology recommends beta-blocker prescription after ST-segment elevation myocardial infarction (STEMI).
Christel Bruggmann, Stéphane Fournier, Alice Panchaud, Olivier Muller, Farshid Sadeghipour, Pierre Voirol   +5 more
doaj   +1 more source

Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease

ESC Heart Failure, 2021
Aims The number of patients with both chronic obstructive pulmonary disease (COPD) and heart failure (HF) is increasing in Asia, and these conditions often coexist.
Yoshiaki Kubota, Wan Ting Tay, Tiew‐Hwa Katherine Teng, Kuniya Asai, Takashi Noda, Kengo Kusano, Atsushi Suzuki, Nobuhisa Hagiwara, Shinji Hisatake, Takanori Ikeda, Ryobun Yasuoka, Takashi Kurita, Wataru Shimizu, ASIAN‐HF Executive Committee   +13 more
doaj   +1 more source

Beta‐blocker use and mortality among patients with systolic heart failure and pacemaker rhythm

ESC Heart Failure, 2023
Aims Beta‐blockers are proven to improve survival among patients with heart failure with reduced ejection fraction. Their efficacy in patients with heart failure with reduced ejection fraction and pacemaker devices has not been demonstrated.
Andrew S. Perry, Aldo P. Maggioni, Luigi Tavazzi, Wayne C. Levy   +3 more
doaj   +1 more source

Evaluation of beta-blocker effects on patients with traumatic brain injury: interventional double-blinded randomized controlled trial

Ain Shams Journal of Anesthesiology, 2023
Background Traumatic brain injury (TBI) is a major cause of death and disability throughout the world. Traumatic injury is one of the most common causes of death in people under the age of 40 worldwide, and one-third of all trauma-related deaths are a ...
Mostafa Saieed Mansour, Nihal Shahat El Seidy, Yasser Ibrahim Fathey   +2 more
doaj   +1 more source

Impact of Beta‐Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population‐Based Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundRelevant clinical studies have been small and have not convincingly demonstrated whether the perioperative initiation of beta‐blockers should be considered in patients with diabetes mellitus undergoing noncardiac surgery.
Ray‐Jade Chen, Hsi Chu, Lung‐Wen Tsai   +2 more
doaj   +1 more source

Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression. [PDF]

PLoS ONE, 2018
Stroke-induced immunodepression is a well characterized complication of acute ischemic stroke. In experimental studies beta-blocker therapy reversed stroke-induced immunodepression, reduced infection rates and mortality.
Ilko L Maier, Johannes C Becker, Johanna Rosemarie Leyhe, Marlena Schnieder, Daniel Behme, Marios-Nikos Psychogios, Jan Liman   +6 more
doaj   +1 more source

Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients

Cardiovascular Diabetology, 2019
Background Although beta blockers could increase the risk of hypoglycemia, the difference between subtypes on hypoglycemia and mortality have not been studied.
Kathleen Dungan, Jennifer Merrill, Clarine Long, Philip Binkley   +3 more
doaj   +1 more source